Belgium· BE-AMP-SAM666314-00
Redemplo 25 mg
A medicinal product containing plozasiran sodium, registered in Belgium by Arrowhead Pharmaceuticals Ireland.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Plozasiran Sodium
- Manufacturer
- Arrowhead Pharmaceuticals Ireland
- Country
- Belgium (BE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Plozasiran sodium in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2766260f-3931-4179-afda-10d7d7e9d1dd GET /v1/drugs/2766260f-3931-4179-afda-10d7d7e9d1dd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection in pre-filled syringe",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Redemplo 25 mg",
"name_fr": "Redemplo 25 mg",
"name_nl": "Redemplo 25 mg",
"amp_code": "SAM666314-00",
"strengths": [
"50.0000"
],
"pack_count": 1,
"substances": [
"Plozasiran Sodium",
"Plozasiran",
"Sodium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": null,
"authorisation_numbers": [
"EU/1/26/2041/001"
]
}See everything about plozasiran sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.